scholarly journals Left atrial spontaneous echo contrast: relationship with clinical and echocardiographic parameters

2019 ◽  
Vol 6 (2) ◽  
pp. R65-R73 ◽  
Author(s):  
Takahide Ito ◽  
Michihiro Suwa

Spontaneous echo contrast (SEC) indicates blood stasis in cardiac chambers and major vessels, and is a known precursor of thrombus formation. Transesophageal echocardiography plays a pivotal role in detecting and grading SEC in the left atrial (LA) cavity. Assessing LA SEC can identify patients at increased risk for thromboembolic events. LA SEC also develops in patients who have sinus rhythm, especially in those with heart failure. Detection of LA SEC is not uncommon in subjects who have multiple cardiovascular comorbidities, although mechanisms behind this association are not fully understood. In patients with atrial fibrillation, the role of mitral regurgitation in counteracting LA SEC and subsequent thromboembolism is controversial. Moreover, alterations of blood coagulability and elevated levels of certain biological markers in the blood contribute to occurrence of LA SEC. This review describes the pathogenesis and assessment of SEC, in addition to the relationship between LA SEC and clinical, biological and echocardiographic parameters.

2022 ◽  
Author(s):  
Changsheng Ma ◽  
Li Wang ◽  
Yuzhu Miao ◽  
Jiali Fan ◽  
Bingyuan Zhou ◽  
...  

Abstract Background: Left atrial appendage (LAA) spontaneous echocardiographic contrast (SEC), sludge and thrombus were associated with a high incidence of thrombus formation and thromboembolic events in patients with non-valvular atrial fibrillation (AF). We aim to identify the main echocardiographic parameters associated with LAA SEC or LAA sludge/thrombus in nonvalvular AF patients.Methods and results: 298 patients with nonvalvular atrial fibrillation were included in the current study between September 2019 and January 2021. Transthoracic echocardiography and transesophageal echocardiography were performed before scheduled electrical cardioversion. LA diameter and maximum left atrial appendage area were increased in the LAA SEC group than control group, and were further increased in patients with LAA sludge or thrombus. LAA-EV, LAA-FV, anterior mitral annular plane systolic excursion (MAPSE) and LAA FAC were lower in the group with LAA SEC than control group, and were further reduced in LAA sludge or thrombus group. Lower LAA FAC and anterior MAPSE were associated with an increased risk of LAA SEC or LAA sludge/thrombus, and LAA FAC and anterior MAPSE showed high accuracy on predicting LAA SEC or LAA sludge/thrombus.Conclusion: Left atrial appendage FAC and anterior MAPSE improves left atrial appendage stasis in patients with nonvalvular atrial fibrillation.


Author(s):  
Danila Vella ◽  
Alessandra Monteleone ◽  
Giulio Musotto ◽  
Giorgia Maria Bosi ◽  
Gaetano Burriesci

Atrial fibrillation (AF) is a common arrhythmia mainly affecting the elderly population, which can lead to serious complications such as stroke, ischaemic attack and vascular dementia. These problems are caused by thrombi which mostly originate in the left atrial appendage (LAA), a small muscular sac protruding from left atrium. The abnormal heart rhythm associated with AF results in alterations in the heart muscle contractions and in some reshaping of the cardiac chambers. This study aims to verify if and how these physiological changes can establish hemodynamic conditions in the LAA promoting thrombus formation, by means of computational fluid dynamic (CFD) analyses. In particular, sinus and fibrillation contractility was replicated by applying wall velocity/motion to models based on healthy and dilated idealized shapes of the left atrium with a common LAA morphology. The models were analyzed and compared in terms of shear strain rate (SSR) and vorticity, which are hemodynamic parameters directly associated with thrombogenicity. The study clearly indicates that the alterations in contractility and morphology associated with AF pathologies play a primary role in establishing hemodynamic conditions which promote higher incidence of ischaemic events, consistently with the clinical evidence. In particular, in the analyzed models, the impairment in contractility determined a decrease in SSR of about 50%, whilst the chamber pathological dilatation contributed to a 30% reduction, indicating increased risk of clot formation. The equivalent rigid wall model was characterized by SSR values about one order of magnitude smaller than in the contractile models, and substantially different vortical behavior, suggesting that analyses based on rigid chambers, although common in the literature, are inadequate to provide realistic results on the LAA hemodynamics.


Author(s):  
Sandeep Panikker ◽  
Tim Betts ◽  
Milena Leo

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting 1.5–2% of the general population and more than 8% of those older than 80 years. Because of the progressive ageing of our population, an exponential increase in incidence is expected over the next few decades. Patients with AF have an increased mortality and morbidity, particularly owing to fatal or disabling stroke. The risk of embolic stroke is five times higher in the presence of AF, with an average annual rate around 5%, but there is a progressive increase with age and the presence of other risk factors, such as prior stroke or transient ischaemic attack, hypertension, diabetes mellitus, congestive heart failure, female sex, and vascular disease, as predicted by the CHADS2 and the CHA2DS2-VASc scores. Moreover, strokes associated with AF are more severe, with a 50% greater likelihood of becoming disabled or handicapped and more than 50% likelihood of death. Intracardiac thrombus formation due to the Virchow triad of events (endothelial or endocardial damage or dysfunction, abnormal blood stasis, and altered haemostasis, platelet function, and fibrinolysis) followed by distal embolization leads to thromboembolic events manifest as transient ischaemic attack, ischaemic stroke, and peripheral embolism in patients with AF.


Medicina ◽  
2019 ◽  
Vol 55 (9) ◽  
pp. 511 ◽  
Author(s):  
Enrico Melillo ◽  
Giuseppe Palmiero ◽  
Adele Ferro ◽  
Paola Elvira Mocavero ◽  
Vittorio Monda ◽  
...  

Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of stroke and thromboembolic complications. A rhythm control strategy with both electrical and pharmacological cardioversion is recommended for patients with symptomatic atrial fibrillation. Anticoagulant therapy for 3–4 weeks prior to cardioversion is recommended in order to avoid thromboembolic events deriving from restoring sinus rhythm. Transesophageal echocardiography has a pivotal role in this setting, excluding the presence of left atrial appendage thrombus before cardioversion. The aim of this review is to discuss the epidemiology and risk factors for left atrial appendage thrombosis, the role of echocardiography in the decision making before cardioversion, and the efficacy of different anticoagulant regimens on the detection and treatment of left atrial appendage thrombosis.


2015 ◽  
Vol 2015 ◽  
pp. 1-13 ◽  
Author(s):  
Damiano Regazzoli ◽  
Francesco Ancona ◽  
Nicola Trevisi ◽  
Fabrizio Guarracini ◽  
Andrea Radinovic ◽  
...  

Atrial fibrillation (AF) is the most common clinically relevant cardiac arrhythmia. AF poses patients at increased risk of thromboembolism, in particular ischemic stroke. The CHADS2 and CHA2DS2-VASc scores are useful in the assessment of thromboembolic risk in nonvalvular AF and are utilized in decision-making about treatment with oral anticoagulation (OAC). However, OAC is underutilized due to poor patient compliance and contraindications, especially major bleedings. The Virchow triad synthesizes the pathogenesis of thrombogenesis in AF: endocardial dysfunction, abnormal blood stasis, and altered hemostasis. This is especially prominent in the left atrial appendage (LAA), where the low flow reaches its minimum. The LAA is the remnant of the embryonic left atrium, with a complex and variable morphology predisposing to stasis, especially during AF. In patients with nonvalvular AF, 90% of thrombi are located in the LAA. So, left atrial appendage occlusion could be an interesting and effective procedure in thromboembolism prevention in AF. After exclusion of LAA as an embolic source, the remaining risk of thromboembolism does not longer justify the use of oral anticoagulants. Various surgical and catheter-based methods have been developed to exclude the LAA. This paper reviews the physiological and pathophysiological role of the LAA and catheter-based methods of LAA exclusion.


2018 ◽  
Vol 19 (2) ◽  
pp. 147032031878262 ◽  
Author(s):  
Ya Suo ◽  
Zhiwei Zhang ◽  
Huaying Fu ◽  
Yue Zhang ◽  
Meng Yuan ◽  
...  

Aims: We examined whether the use of a renin-angiotensin-aldosterone system (RAS) inhibitor plays a role in protecting against left atrial appendage thrombus (LAAT) in patients with hypertension complicated by atrial fibrillation (AF). Methods: Two observational studies were conducted on patients with diagnoses of hypertension and AF, who were categorized into RAS inhibitor user or nonuser groups. Demographic characteristics, clinical characteristics, echocardiographic parameters and hemostatic markers were examined and the occurrence of LAAT during follow-up were recorded. Results: In the first study ( n = 131), LA peak systolic strain and LAA emptying flow velocity (LAA eV) were significantly increased in patients on RAS inhibitors compared with the nonuser group ( p < 0.05). Lower D-dimer and fibrinogen levels were observed in patients on RAS inhibitors ( p < 0.05). In the second study ( n = 99), 25.9% ( n = 11) of patients on RAS inhibitors developed LAAT, compared with 46.7% ( n = 21) in the nonuser group ( p < 0.05). After controlling for risk factors related to LAAT, use of RAS inhibitors remained associated with a significantly lower risk of developing LAAT (HR, 0.406; 95% CI, 0.191–0.862; p = 0.019). Conclusions: RAS inhibitors use was associated with a significant reduction in the risk of LAAT in patients with hypertension and AF.


2018 ◽  
Vol 46 ◽  
pp. 5 ◽  
Author(s):  
Alessandra Michelly Ferreira ◽  
Simone Tostes de Oliveira Stedile ◽  
Vinícius Bentivóglio Costa Silva ◽  
Marios Gonçalves Souza

Background: Aortic stenosis refers to several types of anatomic and functional obstructions of the left ventricular outflow tract. In small animals, this anomaly is most commonly documented as either a congenital lesion or an obstruction that develops soon after birth. It is a hereditary disease, caused by a dominant autosomal gene and modifying genes that interfere with phenotype expression. Even though aortic thromboembolism may be a potential complication in cats with cardiac diseases, aortic stenosis is deemed rare in that species. In this paper, we report an unusual case of a Persian kitten with aortic stenosis that eventually developed arterial thromboembolism.Case: A 7-month-old Persian kitten (3.1 kg) was admitted to a Veterinary Teaching Hospital with a history of hindlimbs paralysis over the past 48 h, as well as excessive vocalization. Also, the cat presented with inappetence, adipsia, urine incontinence, and hematuria. On physical examination, we observed hypothermia and cold paws. The footpads were cyanotic and there were no palpable femoral pulses. Cardiac auscultation disclosed a regular fast pace (200 bpm) and a grade 2/6 murmur heard best over the left cardiac base, but irradiating to the contralateral hemithorax. Prothrombin time and activated partial thromboplastin time were within the normal reference range, but the complete blood count showed microcytosis, lymphopenia, and hyperproteinemia. Also, elevated alanine aminotransferase and BUN were identified. On the echocardiogram, we observed a subvalvular aortic stenosis, which resulted in concentric remodeling of the left ventricle and a mild left atrial dilation. The stenotic lesion was classified as mild. Also, the thoracic radiography unveiledcardiomegaly. The recommended therapy included atenolol (6.25 mg/cat PO, q24h), clopidogrel (18.7 mg/cat PO, q24h), enoxaparin (1 mg/kg SC, q24 h), methadone (0.2 mg/kg IM, q8h) and amoxicillin + potassium clavulanate (20 mg/kg SC, q12h). Additional recommendations included physical therapy on the hindlimbs as well as monitoring heart rate and blood pressure every two hours in the first day, and every six hours thereafter during hospitalization. Seven days later, the cat was depressed, extremely lethargic, and did not respond to therapy at all. Also, necrosis was documented on the hindlimb paws. Therefore, in face of the unfavorable prognosis, the owners opted for euthanasia.Discussion: Cats with cardiomyopathy have an increased risk for developing arterial thromboembolism. The dilated left atrium causes blood stasis and, because of the augmented sensitivity of platelets to serotonin, they aggregate and increase the likelihood of thrombi formation. While some thrombi remain within the heart, usually in the left atrial appendage, others may dislodge and follow blood flow to the aortic trifurcation down in the abdomen. That obstruction impairs blood flow to its tributaries such as the iliac and femoral arteries, which are involved with the hind limbs perfusion. Cats with severe stenotic lesions usually carry a bad prognosis, contrasting with our patient in which only a mild stenosis was documented.However, having developed aortic thromboembolism absolutely changed the prognosis for this cat. Although aortic stenosis is an uncommon condition in cats, its occurrence should be considered as differential diagnosis whenever young patients are admitted with a cardiac murmur. If the diagnosis is confirmed, the patient will need periodical re-evaluations due to the possibility of complications such as arterial thromboembolism. This condition carries a bad prognosis. In this case, it was responsible for the decline in clinical condition which eventually was crucial for the owner opting to euthanize the cat.Keywords: congenital heart disease, echocardiography, valve dysplasia, ischemia.


Author(s):  
M V Melnikov ◽  
A V Sotnikov ◽  
S A Vinnichuk ◽  
V M Melnikov ◽  
D S Korostelev

Aim. The purpose of our study was to value the role of potential arterial emboli sources in death cause according to postmortem data collected in deceased from all causes in a multifield hospital.Material and methods. We performed retrospective analysis of 1324 postmortem records of died pa- tients for the past 6 years (2011-2016). We registered patients’ age and sex, thrombus site, definite intravital clinical and anamnestic data, individual features of tanathogenesis.Results. Intravital thrombus formation was found in 64 of died patients (4,8%), mean age 73,9±2,7 years, women 51,5%. In 41 patients (1 group) there were firm wall thrombi in aorta, in 23 patients thrombi were found in heart cameras (2 group), mostly in left atrial appendage (LAA). Generalized atherosclerosis presented more often in 1 group - 95,5% vs 39,1 in 2 group (p<0,005). The most com- mon cause of death in both groups was acute myocardial infarction. In 1 group infarction was often in combination with acute blood supply disturbances in various arterial regions. For deceased of 2 group thromboembolic fatal events were more typical.Conclusion. It was found that the most dangerous thrombi regarding thromboembolic events were intracardiac ones, mainly in LAA. Aortic wall thrombi have become the marker of generalized athero- sclerosis. The last ones predetermined high probability of ischemic complications in multivessel areas.


Sign in / Sign up

Export Citation Format

Share Document